Word of the Day

Exchange-Traded Fund

In the wide and varied family of the thousands and thousands of funds out there, the exchange-traded fund is one of the more consumer-friendly ones.

Unlike mutual funds, exchange-traded funds, or ETFs, behave more like stocks. You can buy into an ETF at any time, and sell it whenever you feel like it. And like a stock, an ETF's value can rise and fall--depending on what the ETF is invested in.What do ETFs invest in? Well, they're typically linked to an index like the Dow Jones Industrial Average or the S&P 500. So, if you had an ETF that trades the same companies that make up the Dow or the S&P, it will rise and fall in value pretty much the same amount as the Dow or S&P.

You can also buy ETFs that invest in other types of products, like bonds, currencies, gold or other commodities. The ETF market has grown considerably in the past few years, so there is no shortage of ETFs to invest in.

Home / Markets / Industries / Health Care

Wednesday, July 23, 2008

Obagi Medical Products to Report Second Quarter 2008 Financial Results and Host a Conference Call on August 11

Email this Story | Respond to Editor | Print

Comtex

LONG BEACH, Calif., Jul 23, 2008 (BUSINESS WIRE) ----Obagi Medical Products, Inc. (Nasdaq:OMPI), today announced second quarter 2008 financial results will be released after market close on Monday, August 11 and will be followed by an investor conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).

Investors interested in participating in the live call can dial (800) 762-8795 from the U.S. International callers can dial (480) 629-9029. A telephone replay will be available approximately two hours after the call concludes and will be available through Monday, August 25, by dialing (800) 406-7325 from the U.S., or (303) 590-3030 for international callers and entering confirmation code 3903043.

There also will be a simultaneous webcast available on the Investor Relations section of the Company's web site at www.obagi.com. For those unable to participate during the live broadcast, the webcast will be archived for 30 days.

About Obagi Medical Products, Inc.

Obagi Medical Products develops and commercializes skin health products for the dermatology, plastic surgery, and related aesthetic markets. Using its Penetrating Therapeutics(TM) technologies, its products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions including chloasma, melasma, senile lentigines, acne vulgaris and sun damage. Obagi has introduced the following skin care products: Obagi Nu-Derm(R), 1988; Obagi-C(R) Rx (the first and only prescription-strength vitamin C and hydroquinone system), 2004; Obagi(R) Professional-C (a line of highly stable vitamin C serums), 2005; Obagi(R) Condition and Enhance for use with cosmetic procedures, 2006; Obagi ELASTIderm(TM) eye treatment and Obagi CLENZIderm(R) M.D. acne therapeutic systems, 2007; a formulation of Obagi CLENZIderm(R) M.D. Systems for normal to dry skin, June 2007; and Obagi ELASTIderm(TM) Decolletage System, January 2008. Visit www.obagi.com for more information.

SOURCE: Obagi Medical Products, Inc.

Company:
   Obagi Medical Products, Inc. Preston Romm CFO, EVP of Finance, Operations and Administration 562-628-1007 or Investors: ICR,
   Inc. Ina McGuinness/Lena Adams, 310-954-1100